|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 11/01/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/31/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/30/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/25/2007 | 3:30PM | PR Newswire (US) | ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/10/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/08/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Appoints Vice President of Commercialization | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/05/2007 | 3:41PM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/01/2007 | 6:04AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc (Other) (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/01/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Announces Results From Phase 2b Clinical Trial of ANX-510 (CoFactor(R)) | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/01/2007 | 12:09AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Report Results from Phase 2b Clinical Trial of ANX-510 (Cofactor(R)) | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/27/2007 | 6:00AM | PR Newswire (US) | ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/20/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/13/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners' Fifth Annual Growth Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/10/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/04/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 08/29/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 08/16/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer | AMEX:ANX | Mast Therapeutics, Inc. |
| 08/02/2007 | 4:01PM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports Second Quarter 2007 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 07/31/2007 | 3:31PM | PR Newswire (US) | ADVENTRX Reschedules Conference Call and Webcast Discussion of Second Quarter 2007 Results to August 2, 2007 | AMEX:ANX | Mast Therapeutics, Inc. |
| 07/26/2007 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Host Conference Call and Webcast Discussion of Second Quarter 2007 Results on August 3, 2007 | AMEX:ANX | Mast Therapeutics, Inc. |
| 07/23/2007 | 6:00AM | PR Newswire (US) | ANX-201 Combination Therapy Demonstrates Synergistic Inhibition of HIV-1 in Preclinical Tests | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/12/2007 | 7:00AM | PR Newswire (US) | Jack Lief Named Chairman of ADVENTRX Pharmaceuticals | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/07/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Receives Designation as a Small/Medium Enterprise by the European Medicines Agency | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/24/2007 | 10:30AM | PR Newswire (US) | ADVENTRX Executes Agreement With United States Department of Veterans Affairs | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/14/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/09/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at Pharma Finance 2007 Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/07/2007 | 5:01PM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports First Quarter 2007 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/03/2007 | 4:00AM | PR Newswire (US) | ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/02/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at Biotechnology Industry Organization Annual Meeting | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/30/2007 | 7:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Host Conference Call and Webcast Discussion of First Quarter 2007 Results on May 7, 2007 | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|